English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Arena Pharmaceuticals
+
Technology/Innovation
Cheyenne Dickerson
| May 21, 2017
Arena Pharmaceuticals preparing to present ralinepag drug Phase 1 results
Carol Ostrow
| Feb 16, 2017
Arena presenting latest data on ulcerative colitis drug at summit
+
Regulatory
Carol Ostrow
| Jan 13, 2017
Eisai acquires rights to Lorcaserin HCI for weight control
+
Regulatory
Jeff Gantt
| Dec 24, 2016
ANVISA approves Belviq in Brazil
+
Technology/Innovation
Carol Ostrow
| Dec 16, 2016
Arena Pharmaceuticals plans Jan. 12 webcast, conference presentation
+
Technology/Innovation
Jeff Gantt
| Dec 14, 2016
Arena finalizes enrollment in ralinepag trial
+
Community
Amanda Rupp
| May 26, 2016
Arena Pharmaceuticals welcomes new president, CEO
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
